Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 1849
interventional 1233
Observational 523
Registry 93

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 305
Device 230
Drug|placebo 142
Procedure 127
Other 114
Behavioral 102
Diagnostic Test 24
Drug|Procedure 18
Biological 14
Dietary Supplement 13
Dietary Supplement|placebo 13
Device|Drug 12
Behavioral|Drug 11
Biological|placebo 10
Behavioral|Other 9
Device|Procedure 8
Other|Procedure 8
Device|Other 7
Drug|Other 7
Drug|Other|placebo 5
Radiation 5
Behavioral|Procedure 3
Combination Product 3
Device|placebo 3
Genetic 3
Behavioral|Device 2
Behavioral|Drug|Procedure 2
Diagnostic Test|Other 2
Drug|placebo|Procedure 2
Other|placebo 2
placebo|Procedure 2
Behavioral|Biological|Drug 1
Behavioral|Dietary Supplement|Other 1
Behavioral|Drug|Other 1
Behavioral|Drug|placebo 1
Behavioral|Drug|placebo|Procedure 1
Behavioral|Genetic 1
Behavioral|Genetic|Other 1
Biological|Device|Other 1
Biological|Device|placebo 1
Biological|Other 1
Biological|Other|placebo 1
Combination Product|Device 1
Combination Product|Drug|placebo 1
Device|Drug|Other 1
Device|Drug|placebo 1
Device|Drug|Procedure 1
Device|Other|Procedure 1
Dietary Supplement|Drug 1
Dietary Supplement|Drug|Other 1
Drug|Genetic 1
Drug|placebo|Radiation 1
Drug|Procedure|Radiation 1
Genetic|placebo 1
placebo 1
Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 283
NA 143
China 86
Germany 59
Canada 57
United Kingdom 48
Denmark 47
Korea, Republic of 46
Italy 32
France 30
Japan 30
Brazil 26
Switzerland 26
Netherlands 19
Sweden 14
Norway 13
Poland 13
Russian Federation 12
United States|Canada 11
Finland 10
India 10
Spain 10
Belgium 9
Greece 8
Taiwan 7
Iran, Islamic Republic of 5
Israel 5
Australia 4
Austria 4
Egypt 4
Pakistan 4
Slovenia 4
Portugal 3
Turkey 3
Chile 2
Colombia 2
Colombia|Italy 2
Czech Republic 2
Denmark|Sweden 2
Ecuador 2
Ireland 2
Jordan 2
Mexico 2
United States|Australia 2
United States|Ireland|Netherlands|Sweden 2
United States|United Kingdom 2
Argentina 1
Argentina|Austria|Belgium|Brazil|Denmark|France|Germany|Hungary|Italy|Latvia|Netherlands|Norway|Poland|Spain|Switzerland 1
Australia|Belgium|Brazil|Germany|Netherlands|New Zealand|Poland|Switzerland 1
Australia|Belgium|Denmark|France|Germany|Netherlands|New Zealand|Portugal|Switzerland|United Kingdom 1
Australia|Belgium|Denmark|France|Netherlands|New Zealand|Poland|Switzerland 1
Australia|Belgium|New Zealand 1
Australia|France|Netherlands|Sweden|United Kingdom 1
Australia|Malaysia|New Zealand|Singapore 1
Austria|Belgium|China|Germany|Hong Kong|Italy|Netherlands|Portugal|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
Austria|Belgium|Czech Republic|Denmark|Germany|Lithuania|Netherlands|Poland|Romania|Sweden|Switzerland 1
Austria|Belgium|Denmark|France|Germany|India|Italy|Netherlands|New Zealand|Poland|South Africa|Spain|Switzerland 1
Austria|Belgium|Hungary|Netherlands|Poland 1
Austria|Belgium|United States|Argentina|Australia|Brazil|Canada|China|Czechia|Denmark|Finland|France|Germany|Grenada|Hungary|Ireland|Israel|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Puerto Rico|Slovakia|South Africa|Spain|Sweden|Switzerland|United Kingdom 1
Austria|Czechia|Denmark|Germany|Hungary|Ireland|Italy|Latvia|Lithuania|Poland|Portugal|Romania|Serbia|Spain|United Kingdom 1
Austria|Denmark|France|Germany|Greece|Netherlands|Portugal|Spain 1
Austria|Denmark|Germany|Hungary|Switzerland 1
Austria|Denmark|Germany|Switzerland 1
Austria|France|Germany|Israel|Italy|Malaysia|Netherlands|Poland|Spain|Thailand|United Kingdom 1
Austria|France|Germany|Italy|Netherlands|Switzerland|United Kingdom 1
Austria|Germany|Switzerland 1
Austria|Hungary 1
Belgium|Brazil|Czechia|Latvia|Macedonia, The Former Yugoslav Republic of|Netherlands|Poland|Spain|United Kingdom 1
Belgium|Brazil|Denmark|Germany|Netherlands|Singapore|Spain|Switzerland 1
Belgium|Brazil|Denmark|Germany|New Zealand|Poland 1
Belgium|Czech Republic|France|Germany|Netherlands|Spain|Sweden|United Kingdom 1
Belgium|Denmark|Estonia|Finland|Germany|Ireland|Italy|Latvia|Netherlands|Norway|Poland|Sweden|United Kingdom 1
Belgium|France|Luxembourg|Netherlands 1
Belgium|France|Netherlands|New Zealand|Sweden|United Kingdom 1
Belgium|Germany|Israel|Sweden 1
Belgium|Germany|Netherlands|Switzerland 1
Belgium|Italy|Netherlands 1
Belgium|New Zealand 1
Belgium|United Kingdom 1
Brazil|Indonesia|Macedonia, The Former Yugoslav Republic of|Malaysia 1
Bulgaria|United States|Argentina|Australia|Canada|Czechia|Denmark|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
Cameroon|Canada|Italy|Spain|United Kingdom| 1
Canada|Czech Republic|France|Poland|Romania|Russian Federation|Slovakia 1
Canada|New Zealand 1
China|Hong Kong 1
China|Korea, Republic of 1
Denmark|Estonia|Finland|France|Norway|Spain|Sweden|United Kingdom 1
Denmark|Finland|Latvia|Sweden 1
Denmark|Finland|Sweden 1
Denmark|France|Germany|Italy|Japan|Lithuania|Netherlands|Poland|Spain|Sweden|Switzerland 1
Denmark|Germany|Netherlands 1
Denmark|Netherlands|Spain 1
Denmark|Netherlands|Spain|Sweden 1
Denmark|Poland 1
Finland|France|Germany|Italy|Netherlands|Poland|Spain|Switzerland|United Kingdom 1
France|Germany 1
France|Germany|Italy|Netherlands 1
France|Germany|Italy|Serbia|Spain 1
France|Germany|Italy|Spain|Switzerland 1
France|Germany|Netherlands 1
Georgia|Russian Federation 1
Germany|Moldova, Republic of|Netherlands 1
Greece|Hungary|India|Netherlands|Spain|Sweden|Thailand|Tunisia|Turkey|Ukraine|Germany|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czech Republic|Denmark|Egypt|France|Israel|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Morocco|New Zealand|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|United Kingdom 1
Greece|Hungary|Ireland|Poland|Portugal|Russian Federation|Slovakia|Switzerland| 1
Hong Kong 1
Hong Kong|Taiwan 1
Hungary 1
Indonesia 1
Ireland|Austria|Belgium|Canada|China|Czech Republic|France|Germany|Greece|India|Israel|Italy|Malaysia|Netherlands|New Zealand|Portugal|Singapore|South Africa|Spain|Sweden|Switzerland|Thailand|United Kingdom 1
Israel|Netherlands|South Africa|United States|Belgium|Denmark|United Kingdom 1
Italy|United Kingdom 1
Japan|Philippines 1
Japan|Poland|Portugal|Ukraine|United States|Argentina|Australia|Brazil|Bulgaria|Canada|China|Czechia|Denmark|Estonia|France|Germany|Greece|Hungary|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Romania|Russian Federation|Slovakia|South Africa|Spain|Sweden|Turkey|United Kingdom 1
Latvia 1
Lebanon 1
Netherlands|Spain 1
New Zealand 1
Norway|United States|Australia|Belgium|Canada|Czechia|Denmark|France|Hungary|Korea, Republic of|Lithuania|Netherlands|New Zealand|Serbia|Sweden|United Kingdom 1
Palestinian Territory, occupied 1
Poland|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Denmark|France|Germany|India|Israel|Italy|Japan|Malaysia|Netherlands|New Zealand|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
Portugal|Argentina|Australia|Austria|Belgium|Brazil|China|Denmark|France|Germany|Greece|Hungary|India|Israel|Italy|Latvia|Malaysia|Netherlands|Norway|Poland|Russian Federation|South Africa|Spain|Switzerland|United Kingdom|Venezuela 1
Romania 1
Spain|United States|Australia|Austria|Belgium|Canada|France|Germany|Ireland|Italy|Netherlands|South Africa|Switzerland|United Kingdom| 1
Sri Lanka 1
Thailand 1
Trinidad and Tobago 1
Ukraine 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Egypt|France|Germany|Hungary|India|Israel|Italy|Japan|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|North Macedonia|Peru|Poland|Portugal|Romania|Russian Federation|Saudi Arabia|Serbia|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|Czech Republic|France|India|Korea, Republic of|Mexico|Netherlands|Poland|Portugal|Russian Federation|Spain|Turkey 1
United States|Argentina|Australia|Belgium|Brazil|Canada|France|Hungary|Italy|Mexico|Netherlands|Poland|Russian Federation|Spain 1
United States|Argentina|Australia|Belgium|Canada|France|Germany|Hungary|Italy|Poland|Spain 1
United States|Argentina|Australia|Bulgaria|Canada|Denmark|Estonia|France|Germany|Hungary|India|Netherlands|New Zealand|Pakistan|Romania|Spain 1
United States|Argentina|Brazil|Chile|Colombia|Lithuania|Netherlands|Peru|Venezuela 1
United States|Argentina|Peru|Puerto Rico 1
United States|Australia|Belgium|Canada|Denmark|Germany|Hungary|Israel|Korea, Republic of|Netherlands|New Zealand|Spain|Switzerland 1
United States|Australia|Belgium|Canada|France|Italy|Netherlands|Poland|Spain 1
United States|Australia|Belgium|Canada|France|Italy|Netherlands|Spain 1
United States|Australia|Canada|China|Czech Republic|Denmark|France|Hungary|Mexico|Netherlands|Poland|Spain|United Kingdom 1
United States|Australia|Canada|Germany 1
United States|Australia|Canada|Singapore 1
United States|Australia|Czechia|Germany|Hungary|Italy|Netherlands 1
United States|Australia|Germany|New Zealand 1
United States|Belarus|Bulgaria|Canada|Czech Republic|Georgia|Germany|Israel|Poland|Russian Federation|Serbia|Slovakia|Slovenia|Ukraine 1
United States|Belgium|Canada|Czech Republic|Germany|Hungary|Netherlands|Poland|Russian Federation|Spain|Sweden 1
United States|Belgium|Canada|Czechia|Denmark|France|Germany|Hungary|Italy|Netherlands|Serbia|Sweden|United Kingdom 1
United States|Belgium|Canada|France|Germany|Hungary|Italy|Netherlands|Spain|Switzerland|United Kingdom 1
United States|Belgium|Canada|Japan|Netherlands|Spain|Switzerland|United Kingdom 1
United States|Belgium|Canada|Netherlands|Poland|Spain 1
United States|Brazil|Canada|Denmark|Germany|Japan|Netherlands|Singapore 1
United States|Brazil|India|Italy|Korea, Republic of|Poland 1
United States|Canada|Czech Republic|Finland|Israel|Italy|Singapore|United Kingdom 1
United States|Canada|Czech Republic|Germany|Hungary|New Zealand|Norway|Slovakia|South Africa 1
United States|Canada|Czech Republic|Germany|South Africa|United Kingdom 1
United States|Canada|Denmark 1
United States|Canada|Denmark|Netherlands|Singapore|Sweden|United Kingdom 1
United States|Canada|Denmark|United Kingdom 1
United States|Canada|Finland|France|Germany|Netherlands 1
United States|Canada|Finland|Puerto Rico 1
United States|Canada|Germany|United Kingdom 1
United States|Colombia 1
United States|Czechia|Netherlands|United Kingdom 1
United States|Denmark|Germany|Israel|Netherlands 1
United States|France|Germany|Korea, Republic of|New Zealand|Switzerland|United Kingdom 1
United States|Germany 1
United States|Japan 1
United States|Netherlands 1
United States|Poland 1
United States|Puerto Rico 1
United States|Ukraine 1
Venezuela 1

Sites per Study

Site_count Study_Count
1 876
2 73
3 29
4 18
5 22
6 17
7 8
8 10
9 13
10 12
11 7
12 11
13 8
14 5
15 7
16 6
17 9
18 4
19 3
20 4
23 4
24 3
25 4
26 2
27 2
28 4
29 2
30 2
32 2
33 3
34 3
36 2
38 1
39 2
41 2
43 1
44 1
45 1
46 2
48 2
49 1
50 1
51 1
52 1
56 1
58 1
59 1
60 1
61 1
62 2
64 1
65 1
69 1
73 1
74 1
81 1
82 1
86 1
92 2
93 1
95 1
102 1
112 1
119 1
120 1
121 1
122 1
124 1
128 1
135 1
144 1
147 1
150 1
154 1
177 1
195 2
241 1
314 1
320 1
471 1
578 1
584 1
1091 1

Phase

Phase Study_Count
N/A 538
Phase 4 241
Phase 3 207
Phase 2 142
Phase 1 46
Phase 2/Phase 3 34
Phase 1/Phase 2 16
Early Phase 1 9

Number of Arms

Number_of_Arms Count_of_Studies
1 200
2 657
3 115
4 42
5 4
6 11
7 1
8 2
11 1
NA 200

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 20 4.0000 5.0000 10.00 2.0000 18.0000 12.000 11.0000
1st Qu. 30 54.0000 15.2500 24.75 33.5000 50.0000 117.250 61.0000
Median 40 123.0000 31.0000 39.50 80.0000 70.5000 400.000 144.0000
Mean 49 642.2892 231.4565 99.25 229.3333 280.5882 1738.878 746.0377
3rd Qu. 50 400.0000 67.0000 75.00 150.0000 332.2500 845.500 594.0000
Max. 100 61301.0000 8400.0000 643.00 10000.0000 3043.0000 39876.000 22000.0000

Trial Group Type

group_type Group_Count
Experimental 981
Active Comparator 650
Placebo Comparator 216
NA 200
No Intervention 150
Other 130
Sham Comparator 20

Intervention Model

intervention_model Study_Count
Parallel Assignment 765
Single Group Assignment 280
Crossover Assignment 80
NA 67
Factorial Assignment 32
Sequential Assignment 9

Primary Purpose

primary_purpose Study_Count
Treatment 730
Prevention 170
Diagnostic 158
Basic Science 52
Health Services Research 28
Supportive Care 28
Other 27
NA 26
Screening 12
Device Feasibility 1
Educational/Counseling/Training 1

Observational Studies

Studies by Country

Country Study_Count
NA 108
United States 101
China 29
Germany 26
Korea, Republic of 26
United Kingdom 21
Canada 16
Italy 15
Netherlands 13
Switzerland 13
France 12
Denmark 11
Norway 10
Sweden 10
Israel 7
Austria 6
Poland 6
Russian Federation 6
Singapore 6
Finland 5
Greece 5
Japan 5
Belgium 4
India 4
Turkey 4
Brazil 3
Taiwan 3
Croatia 2
Egypt 2
Hong Kong 2
Romania 2
Spain 2
United States|Canada 2
United States|Denmark 2
Australia 1
Austria|Belgium|Denmark|France|Germany|Hungary|Ireland|Italy|Netherlands|Spain|United Kingdom 1
Austria|Germany 1
Bangladesh 1
Belgium|France 1
Belgium|France|Germany|Hungary|Ireland|Italy|Latvia|Poland|Spain|United Kingdom 1
Belgium|France|Germany|Italy|Switzerland 1
Belgium|Germany|Italy|Switzerland 1
Belgium|Singapore 1
Belgium|Sweden|United Kingdom 1
Brazil|Germany|Italy|United Kingdom 1
Bulgaria 1
China|India|Malaysia|Sri Lanka|Vietnam 1
Denmark|France|Germany|Italy|Japan|Netherlands|United Kingdom 1
Denmark|Netherlands|New Zealand|Poland 1
Ecuador 1
Estonia 1
Germany|Italy|Portugal|Spain 1
Hungary 1
Iran, Islamic Republic of 1
Italy|Austria|Belgium|Bulgaria|Germany|Netherlands|Poland|Switzerland|United Kingdom 1
Portugal 1
Portugal|Spain 1
Qatar 1
Spain|Sweden 1
Spain|United Kingdom 1
Spain|United States|Belgium|Denmark|France|Germany|Italy|Netherlands|Poland|Sweden|Switzerland|United Kingdom 1
Trinidad and Tobago 1
United States|Austria|Canada|Germany|Italy|Korea, Republic of|Switzerland 1
United States|Canada|China|Italy|Japan|Korea, Republic of|Latvia|Netherlands 1
United States|Canada|Puerto Rico 1
United States|Denmark|France|Italy|Latvia|Netherlands|Poland|United Kingdom 1
United States|Germany|Ireland|Japan|Netherlands|Spain|United Kingdom 1
United States|Saudi Arabia 1

Sites per Study

Site_count Study_Count
1 400
2 29
3 8
4 13
5 9
6 7
7 3
8 6
9 3
10 5
12 2
13 3
14 1
17 1
18 4
19 2
20 2
22 1
23 4
24 1
25 1
29 1
33 2
37 1
38 1
40 4
43 1
47 1
50 2
58 1
81 1
90 1
107 1
183 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 100.000
Median 309.000
Mean 4971.047
3rd Qu 1165.000
Max 700000.000

Observation Model

observational_model Study_Count
Cohort 282
NA 84
Case-Only 59
Other 31
Case Control 25
Case-Control 23
Case-Crossover 4
Defined Population, Natural History 4
Ecologic or Community 4
Defined Population 3
Family-Based 2
Case Control, Natural History 1
Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 334
Retrospective 62
Cross-Sectional 55
NA 55
Other 8
Longitudinal, Prospective 6
Cross-Sectional, Prospective 1
Longitudinal, Retrospective 1
Longitudinal, Retrospective/Prospective 1

Registries

Studies by Country

Country Study_Count
China 15
Korea, Republic of 12
Italy 9
Spain 6
United States 6
Germany 4
NA 4
Netherlands 4
Belgium 3
Greece 3
Russian Federation 3
France 2
Singapore 2
Tunisia 2
Belgium|Hong Kong 1
Belgium|Netherlands 1
Brazil 1
Egypt 1
Finland 1
France|Germany|Switzerland 1
Israel 1
Japan 1
Netherlands|Russian Federation 1
Norway 1
Portugal 1
Spain|Portugal 1
Thailand 1
Turkey 1
United Kingdom 1
United States|Argentina|Canada|India|Italy 1
United States|Canada|Germany|Israel 1
United States|Israel 1

Sites per Study

Site_count Study_Count
1 63
2 4
3 2
4 4
5 1
6 2
7 2
9 2
11 1
13 1
14 1
16 3
18 1
20 1
21 1
24 1
28 1
37 1
44 1

Enrollment Metrics

Measure Registries
Min 28.0
1st Qu 255.0
Median 1005.0
Mean 147607.6
3rd Qu 2000.0
Max 7205000.0

Registry Model

observational_model Study_Count
Cohort 70
Case-Only 12
Other 7
Case-Control 4

Time Perspective

time_perspective Study_Count
Prospective 85
Other 5
Cross-Sectional 1
Retrospective 1
NA 1

Follow-up

target_duration Study_Count
5 Years 22
12 Months 17
1 Year 11
2 Years 8
3 Years 7
1 Day 6
24 Months 5
10 Years 3
18 Months 3
3 Months 2
6 Months 2
1 Month 1
1 Week 1
1095 Days 1
17 Years 1
3 Days 1
36 Months 1
7 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04138238 Cruz HBR Registry - Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Stent https://ClinicalTrials.gov/show/NCT04138238 Recruiting Sahajanand Medical Technologies Pvt. Ltd. 2021-11-30
NCT03373552 Genetic Polymorphism Contributing to the Variability of Clopidogrel Response in Patients With Coronary Artery Disease https://ClinicalTrials.gov/show/NCT03373552 Recruiting Hôpital Universitaire Fattouma Bourguiba 2019-11-15
NCT03479580 Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry https://ClinicalTrials.gov/show/NCT03479580 Recruiting University Hospital, Grenoble 2028-02-29
NCT03824600 Physiological Patterns of Coronary Artery Disease https://ClinicalTrials.gov/show/NCT03824600 Completed Onze Lieve Vrouw Hospital 2019-08-30
NCT03338309 INsTantenous wavE-Free Ratio-guided PCI Versus Fractional Flow REserve-Guided PCI in rouTine Clinical Practice, Prospective, Multicenter Registry https://ClinicalTrials.gov/show/NCT03338309 Active, not recruiting Samsung Medical Center 2022-12-01
NCT03315234 Correlation of Genetic Polymorphisms and Clinical Parameters With the Complexity of Coronary Artery Disease https://ClinicalTrials.gov/show/NCT03315234 Active, not recruiting Aristotle University Of Thessaloniki 2018-06-30
NCT03312179 STEMI and Incretins Treatment https://ClinicalTrials.gov/show/NCT03312179 Completed University of Campania “Luigi Vanvitelli” 2017-09-01
NCT03205514 Multimodality Investigation of Intermediate Culprit Lesion With Negative FFR in NSTE-ACS https://ClinicalTrials.gov/show/NCT03205514 Active, not recruiting University Hospital of Ferrara 2018-06-05
NCT03151018 Effect and Efficacy of Onyxâ„¢, Zotarolimus-eluting Stent for Coronary Atherosclerosis https://ClinicalTrials.gov/show/NCT03151018 Recruiting Seoul National University Hospital 2018-05-31
NCT03150680 Development of a Risk Prediction Algorithm Through the Investigation of Genetic Risk Factors and the Complexity of Coronary Artery Disease to Estimate Future Risk of Cardiovascular Events: Angiographic (SYNTAX Score), Clinical and Pharmacogenetic Analysis. https://ClinicalTrials.gov/show/NCT03150680 Recruiting AHEPA University Hospital 2020-02-29
NCT03139006 Application of speCtraL Computed tomogrAphy to impRove specIficity of Cardiac compuTed tomographY https://ClinicalTrials.gov/show/NCT03139006 Recruiting UMC Utrecht 2021-03-29
NCT03129503 Optical Coherence Tomography in Acute Coronary Syndrome https://ClinicalTrials.gov/show/NCT03129503 Active, not recruiting Charite University, Berlin, Germany 2024-03-31
NCT03085823 The All-comers Sirolimus-coated Balloon European Registry https://ClinicalTrials.gov/show/NCT03085823 Recruiting Fatebenefratelli and Ophthalmic Hospital 2020-12-31
NCT03082989 Evolving Routine Standards in Intracoronary Physiology https://ClinicalTrials.gov/show/NCT03082989 Completed University Hospital of Ferrara 2017-09-30
NCT03079739 Long-term Outcome of Deferred Lesion Based on FFR https://ClinicalTrials.gov/show/NCT03079739 Active, not recruiting University Hospital of Ferrara 2020-09-30
NCT03066141 Evaluation of Association Between Obstructive Sleep Apnea and the Severity of Coronary Artery Disease https://ClinicalTrials.gov/show/NCT03066141 Completed Chinese Pulmonary Vascular Disease Research Group 2019-08-29
NCT03058211 Myocardial Injury and Severe Pneumococcal Pneumonia https://ClinicalTrials.gov/show/NCT03058211 Recruiting Hospital Universitari Joan XXIII de Tarragona. 2020-05-31
NCT03051061 Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation https://ClinicalTrials.gov/show/NCT03051061 Recruiting Henan Institute of Cardiovascular Epidemiology 2019-12-01
NCT03045913 Genoss DES Prospective Multicenter Registry https://ClinicalTrials.gov/show/NCT03045913 Recruiting Yonsei University 2019-12-31
NCT03045848 Biofreedom Prospective Multicenter Observational Registry https://ClinicalTrials.gov/show/NCT03045848 Recruiting Wonju Severance Christian Hospital 2020-06-30
NCT03030495 Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR https://ClinicalTrials.gov/show/NCT03030495 Recruiting Samsung Medical Center 2022-12-31
NCT02996903 Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017 https://ClinicalTrials.gov/show/NCT02996903 Completed Klinikum der Universitaet Muenchen 2017-10-31
NCT02996877 Outcomes of Surgically Ineligible Patients With Multivessel CAD https://ClinicalTrials.gov/show/NCT02996877 Active, not recruiting Saint Luke’s Health System 2020-06-30
NCT02989740 Optical Coherence Tomography Morphologic and Fractional Flow Reserve Assessment in Diabetes Mellitus Patients https://ClinicalTrials.gov/show/NCT02989740 Active, not recruiting Diagram B.V. 2020-06-30
NCT02986295 Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent https://ClinicalTrials.gov/show/NCT02986295 Recruiting Samsung Medical Center 2019-01-31
NCT02888652 Study on the Registration of Coronary Heart Disease Patients Undergoing PCI https://ClinicalTrials.gov/show/NCT02888652 Completed The Third Xiangya Hospital of Central South University 2018-08-31
NCT02854813 Overactive Bladder in Elderly Patients- An Early Warning of Coronary Artery Disease https://ClinicalTrials.gov/show/NCT02854813 Completed Ankara Training and Research Hospital 2017-01-31
NCT02845804 Effect and Efficacy of Xpeditionâ„¢/Alpineâ„¢, Everolimus-eluting Stent for Coronary Atherosclerosis https://ClinicalTrials.gov/show/NCT02845804 Recruiting Seoul National University Hospital 2018-07-31
NCT02817802 BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV https://ClinicalTrials.gov/show/NCT02817802 Recruiting Biotronik AG 2020-10-31
NCT02803411 Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging(PARADIGM) https://ClinicalTrials.gov/show/NCT02803411 Active, not recruiting Yonsei University 2026-01-31
NCT02789943 Multi- Level and Integrated Analysis of Mechanisms Underlying Atrial Dysfunction https://ClinicalTrials.gov/show/NCT02789943 Recruiting National Heart Centre Singapore 2017-07-31
NCT02751060 Evaluation of Plasma Non-coding RNAs as Biomarkers in Coronary Heart Disease https://ClinicalTrials.gov/show/NCT02751060 Enrolling by invitation Tongji Hospital 2019-12-31
NCT02737982 Sex and Gender Differences in Ischemic Heart Disease - Endocrine Vascular Disease Approach https://ClinicalTrials.gov/show/NCT02737982 Recruiting University of Roma La Sapienza 2019-12-31
NCT02635230 What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2. https://ClinicalTrials.gov/show/NCT02635230 Recruiting R&D Cardiologie 2021-01-31
NCT02621216 Tilburg Health Outcomes Registry of Emotional Stress in Coronary Intervention https://ClinicalTrials.gov/show/NCT02621216 Recruiting University of Tilburg 2023-12-31
NCT02440646 Natural History of Atherosclerosis in Real-World Patients Underwent Computed Tomography Angiography https://ClinicalTrials.gov/show/NCT02440646 Enrolling by invitation Ural Medical University 2016-12-31
NCT02410330 Therapeutic Use of Ultrasound in Acute Coronary Artery Disease https://ClinicalTrials.gov/show/NCT02410330 Completed University of Sao Paulo General Hospital 2020-01-31
NCT02364778 Single-centre, Registry Trial, the Patients Presented With Stable Coronary Artery Disease https://ClinicalTrials.gov/show/NCT02364778 Completed Icahn School of Medicine at Mount Sinai 2015-05-31
NCT02313038 Prospective Assessment of Efficacy and Safety of Drug Eluting Stents https://ClinicalTrials.gov/show/NCT02313038 Completed China National Center for Cardiovascular Diseases 2015-07-31
NCT02247492 BIOFLOW-III VIP Russia Registry Orsiro Stent System https://ClinicalTrials.gov/show/NCT02247492 Recruiting Biotronik Russia 2019-04-30
NCT02191306 Utilizing Computed Tomographic Angiography to Evaluate Coronary Artery Disease in Patients on Long-Term Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT02191306 Completed Florida State University 2014-03-31
NCT02186093 Clinical, Physiological and Prognostic Implication of Microvascular Status https://ClinicalTrials.gov/show/NCT02186093 Recruiting Seoul National University Hospital 2020-11-30
NCT02180178 Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registery https://ClinicalTrials.gov/show/NCT02180178 Recruiting Johannes Gutenberg University Mainz 2020-09-30
NCT02026466 Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion https://ClinicalTrials.gov/show/NCT02026466 Completed Saint Luke’s Health System 2017-09-30
NCT02029092 BIOFLOW III Satellite-ELADIS Orsiro Stent System https://ClinicalTrials.gov/show/NCT02029092 Completed C.E.M. Biotronik, S.A. 2016-07-31
NCT02028728 BIOFLOW III Satellite-Italy Orsiro Stent System https://ClinicalTrials.gov/show/NCT02028728 Completed Biotronik Italia S.p.A. 2016-07-31
NCT01977534 To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels https://ClinicalTrials.gov/show/NCT01977534 Completed Abbott Medical Devices 2018-10-31
NCT01917682 Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions https://ClinicalTrials.gov/show/NCT01917682 Completed Corindus Inc. 2016-12-31
NCT01856504 Validation of an Intracycle CT Motion CORrection Algorithm for Diagnostic AccuracY https://ClinicalTrials.gov/show/NCT01856504 Completed MDDX LLC 2015-03-31
NCT01835808 Portuguese Study on The Evaluation of FFR Guided Treatment of Coronary Disease https://ClinicalTrials.gov/show/NCT01835808 Completed Portuguese Society of Cardiology 2013-11-30
NCT01816854 Endovascular Treatment of Atherosclerotic Lesions in the SFA Using the Sinus-superflex-635 Stent https://ClinicalTrials.gov/show/NCT01816854 Completed be Medical 2017-03-29
NCT01808391 A Prospective Multicenter Post Approval Study to Evaluate the Long-term Safety and Efficacy of the Resolute Integrity in the Japanese All-comers Patients With Coronary Artery Disease (PROPEL) https://ClinicalTrials.gov/show/NCT01808391 Completed Associations for Establishment of Evidence in Interventions 2014-05-31
NCT01788592 Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry) https://ClinicalTrials.gov/show/NCT01788592 Recruiting Asan Medical Center 2030-10-31
NCT01787370 Mainz Registry of Flow-mediated Constriction https://ClinicalTrials.gov/show/NCT01787370 Completed Johannes Gutenberg University Mainz 2018-02-01
NCT01759225 Registry of Cardiovascular Disease Patients https://ClinicalTrials.gov/show/NCT01759225 Enrolling by invitation Maccabi Healthcare Services, Israel 2100-12-31
NCT03349385 Registry of Secondary Revascularization https://ClinicalTrials.gov/show/NCT03349385 Active, not recruiting Hospital San Carlos, Madrid 2021-01-15
NCT04444960 Precision Therapy in Complex High-risk Coronary Artery Disease https://ClinicalTrials.gov/show/NCT04444960 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2023-06-30
NCT04347200 REGistry of Long-term AnTithrombotic TherApy-1 https://ClinicalTrials.gov/show/NCT04347200 Recruiting National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 2025-12-31
NCT04305171 Effect of Non-surgical Periodontal Treatment on Cardiovascular Risk Markers https://ClinicalTrials.gov/show/NCT04305171 Completed Mahidol University 2020-01-31
NCT04304677 Automated Algorithm Detecting Physiologic Major Stenosis and Its Relationship With Post-PCI Clinical Outcomes https://ClinicalTrials.gov/show/NCT04304677 Recruiting Samsung Medical Center 2020-12-31
NCT04255563 Drug-coating Balloon Treatment in Coronary Artery Disease https://ClinicalTrials.gov/show/NCT04255563 Recruiting Nanjing First Hospital, Nanjing Medical University 2030-12-30
NCT04234893 Bingo Drug-Coated Balloon in Real World https://ClinicalTrials.gov/show/NCT04234893 Recruiting Yinyi(Liaoning) Biotech Co., Ltd. 2022-09-30
NCT04219761 National Tunisian Registry of Percutaneous Coronary Intervention https://ClinicalTrials.gov/show/NCT04219761 Recruiting Dacima Consulting 2020-09-30
NCT04196712 Essen Coronary Artery Disease Registry https://ClinicalTrials.gov/show/NCT04196712 Recruiting University Hospital, Essen 2022-12-30
NCT04198896 The Sakakibara Health Integrative Profile of Atherosclerotic-Carcinogenesis Hypothesis (SHIP-AC) https://ClinicalTrials.gov/show/NCT04198896 Completed Sakakibara Heart Institute 2019-10-31
NCT04185493 Coronary Artery Geometry and the Severity of Coronary Atherosclerosis https://ClinicalTrials.gov/show/NCT04185493 Recruiting Aristotle University Of Thessaloniki 2021-06-30
NCT04162561 TherApy in stabLe Coronary Artery dIsease Patients According to Clinical GuideliNes (ALIGN) https://ClinicalTrials.gov/show/NCT04162561 Active, not recruiting National Research Center for Preventive Medicine 2022-12-31
NCT04010955 Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON) https://ClinicalTrials.gov/show/NCT04010955 Recruiting Asan Medical Center 2023-08-31
NCT04009421 Coronary Artery Plaque Burden in Stable Angina and Non-obstructive Coronary Artery Disease https://ClinicalTrials.gov/show/NCT04009421 Active, not recruiting University of Bergen 2022-01-31
NCT03999463 Sevoflurane Effect on Left Atrial Performance: A Transoesophageal Echocardiographic Study https://ClinicalTrials.gov/show/NCT03999463 Completed Ain Shams University 2019-09-30
NCT03852082 Predictors and Clinical Outcomes of Patients With Coronary Heart Disease Co-morbid Depression Post Percutaneous Coronary Intervention https://ClinicalTrials.gov/show/NCT03852082 Recruiting Nanjing First Hospital, Nanjing Medical University 2020-04-30
NCT03847753 Exploring the Comorbidity Between Mental Disorders and General Medical Conditions https://ClinicalTrials.gov/show/NCT03847753 Completed University of Aarhus 2016-12-31
NCT03782688 Precise Percutaneous Coronary Intervention Plan (P3) Study https://ClinicalTrials.gov/show/NCT03782688 Recruiting Onze Lieve Vrouw Hospital 2020-01-15
NCT03760705 Singapore Cardiac Longitudinal Outcomes Database https://ClinicalTrials.gov/show/NCT03760705 Active, not recruiting National Heart Centre Singapore 2025-12-31
NCT03749694 Investigating Temporal Improvements in Survival Following ST-elevation Myocardial Infarction. https://ClinicalTrials.gov/show/NCT03749694 Completed University of Leeds 2013-06-30
NCT03691688 The Long Term Effect of Low Dose Aspirin on Uric Acid in Chinese Patients With Coronary Artery Disease(AURORA) https://ClinicalTrials.gov/show/NCT03691688 Recruiting Shanghai Zhongshan Hospital 2021-11-01
NCT03619395 Risc Optimisation- Acute cor5onary Syndrome https://ClinicalTrials.gov/show/NCT03619395 Recruiting Parc de Salut Mar 2020-07-01
NCT03567733 Prospective Registry of Patients Over 75 Years Old Treated With Xience Sierra Stents. Sierra 75 Study https://ClinicalTrials.gov/show/NCT03567733 Active, not recruiting Fundación EPIC 2019-12-01
NCT03531151 MRI of Myocardial Infarction https://ClinicalTrials.gov/show/NCT03531151 Recruiting University of Pennsylvania 2023-03-31
NCT03518437 Coronary Atherosclerosis Disease Early Identification and Risk Stratification by Noninvasive Imaging https://ClinicalTrials.gov/show/NCT03518437 Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital 2019-09-30
NCT03509532 DRUG ELUTING STENT FOR DIABETIC PATIENTS IN CORONARY ARTERY DISEASE TREATMENT https://ClinicalTrials.gov/show/NCT03509532 Recruiting Istituto Clinico Sant’Ambrogio 2019-01-31
NCT03462277 DNA Methylation and Hydroxymethylation Levels in Patients With Coronary Heart Disease https://ClinicalTrials.gov/show/NCT03462277 Completed Chongqing Medical University 2018-08-01
NCT03461367 CTO Registry From Insight of IVUS in Fuwai Hospital https://ClinicalTrials.gov/show/NCT03461367 Recruiting China National Center for Cardiovascular Diseases 2019-12-31
NCT03444259 Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients https://ClinicalTrials.gov/show/NCT03444259 Recruiting University of Turku 2025-12-31
NCT03443999 S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System https://ClinicalTrials.gov/show/NCT03443999 Recruiting Sahajanand Medical Technologies Pvt. Ltd. 2022-06-30
NCT03438448 Perioperative Myocardial Ischemia: Troponin Monitoring,Cost-effectiveness, Insights Into Pathophysiology https://ClinicalTrials.gov/show/NCT03438448 Recruiting Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2019-12-31
NCT03428048 Cardiovascular Innovation & Research Institute ’s NEXUS Registry, the Whole is Greater Than the Parts. https://ClinicalTrials.gov/show/NCT03428048 Recruiting Cardiovascular Innovation and Research Institute 2026-03-31
NCT03767621 Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR https://ClinicalTrials.gov/show/NCT03767621 Recruiting Fundación EPIC 2025-06-30
NCT03745066 BioFreedom French Registry https://ClinicalTrials.gov/show/NCT03745066 Active, not recruiting Biosensors Europe SA 2021-04-30
NCT02929030 Clinical Performance of Nano Plus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease https://ClinicalTrials.gov/show/NCT02929030 Recruiting Xijing Hospital 2018-01-31
NCT03788512 Coexistence of Cerebral and Coronary Atherosclerosis in Acute Ischemic Cerebrovascular Disease Patients Registry https://ClinicalTrials.gov/show/NCT03788512 Recruiting Xuanwu Hospital, Beijing 2022-01-12
NCT01850693 Assessment of Coronary Artery Disease in Stroke Patients https://ClinicalTrials.gov/show/NCT01850693 Completed Seoul National University Hospital 2012-12-31
NCT03890822 Coronary Artery Disease Progression in Patients With Acute Coronary Syndromes and Diabetes Mellitus https://ClinicalTrials.gov/show/NCT03890822 Recruiting Humanitas Hospital, Italy 2022-03-25